Lawrence Steinman

Stanford Medicine, Stanford University

Papers

2

Total Citations

689

H-Index

2

About

Lawrence Steinman is a pioneering immunologist whose research has fundamentally reshaped our understanding of autoimmune diseases, particularly multiple sclerosis (MS). His work centers on the molecular mechanisms driving autoimmunity and the development of targeted therapies to modulate the immune system. Steinman’s most influential contribution is the invention of autoantigen microarrays, a groundbreaking technology that enables the simultaneous, high-throughput profiling of hundreds of autoantibodies from a single blood sample. This innovation, detailed in his 2002 paper with 677 citations, has revolutionized the diagnosis and monitoring of autoimmune conditions, allowing researchers to map disease-specific antibody signatures with unprecedented precision. Beyond this, Steinman has identified new therapeutic targets for MS, exploring pathways to halt neuroinflammation and promote repair. His insights have directly informed the development of several FDA-approved treatments, including natalizumab. With a career spanning decades, Steinman’s work has earned him numerous accolades, including election to the National Academy of Sciences. His research continues to inspire a new generation of scientists seeking to translate immune mechanisms into life-changing therapies.

Research Focus

Key Achievements

2
H-Index
2
Papers
689
Total Citations
345
Avg Citations/Paper
🏆 Most Cited Paper
Autoantigen microarrays for multiplex characterization of autoantibody responses
677 citations · 2002
📈 Most Prolific Year: 2002 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Stanford Medicine, Stanford University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago